文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Wnt Signaling in Cancer Stem Cell Biology.

作者信息

de Sousa E Melo Felipe, Vermeulen Louis

机构信息

Laboratory of Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), Amsterdam 1105AZ, The Netherlands.

出版信息

Cancers (Basel). 2016 Jun 27;8(7):60. doi: 10.3390/cancers8070060.


DOI:10.3390/cancers8070060
PMID:27355964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4963802/
Abstract

Aberrant regulation of Wnt signaling is a common theme seen across many tumor types. Decades of research have unraveled the epigenetic and genetic alterations that result in elevated Wnt pathway activity. More recently, it has become apparent that Wnt signaling levels identify stem-like tumor cells that are responsible for fueling tumor growth. As therapeutic targeting of these tumor stem cells is an intense area of investigation, a concise understanding on how Wnt activity relates to cancer stem cell traits is needed. This review attempts at summarizing the intricacies between Wnt signaling and cancer stem cell biology with a special emphasis on colorectal cancer.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fead/4963802/14fdcabe7228/cancers-08-00060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fead/4963802/f3370448f240/cancers-08-00060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fead/4963802/008b645024bb/cancers-08-00060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fead/4963802/14fdcabe7228/cancers-08-00060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fead/4963802/f3370448f240/cancers-08-00060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fead/4963802/008b645024bb/cancers-08-00060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fead/4963802/14fdcabe7228/cancers-08-00060-g003.jpg

相似文献

[1]
Wnt Signaling in Cancer Stem Cell Biology.

Cancers (Basel). 2016-6-27

[2]
Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells.

Clin Cancer Res. 2014-7-8

[3]
Wnt Signaling in Stem Cells and Tumor Stem Cells.

Semin Reprod Med. 2015-9

[4]
Wnt/β-catenin signaling in bone marrow niche.

Cell Tissue Res. 2016-2

[5]
RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities.

Genes Dis. 2023-4-19

[6]
The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development.

Res Rep Biochem. 2014

[7]
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).

Int J Oncol. 2017-9-19

[8]
Wnt Ligands as a Part of the Stem Cell Niche in the Intestine and the Liver.

Prog Mol Biol Transl Sci. 2018-1-8

[9]
Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.

Pharmacol Ther. 2015-11-2

[10]
Wnt signaling in adult intestinal stem cells and cancer.

Cell Signal. 2013-12-2

引用本文的文献

[1]
High-fat diet driven post-operative colon cancer recurrence is dependent upon genetic susceptibility to deoxycholic acid.

Cancer Lett. 2025-7-22

[2]
Advances and challenges in drug repurposing in precision therapeutics of colorectal cancer.

World J Gastrointest Oncol. 2025-7-15

[3]
Breaking the Resistance: Photodynamic Therapy in Cancer Stem Cell-Driven Tumorigenesis.

Pharmaceutics. 2025-4-24

[4]
Safely Targeting Cancer, the Wound That Never Heals, Utilizing CBP/Beta-Catenin Antagonists.

Cancers (Basel). 2025-4-29

[5]
Cholesterol-targeting Wnt-β-catenin signaling inhibitors for colorectal cancer.

Nat Chem Biol. 2025-4-16

[6]
β-Catenin Drives the FOXC2-Mediated Epithelial-Mesenchymal Transition and Acquisition of Stem Cell Properties.

Cancers (Basel). 2025-3-26

[7]
Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality.

Genes Dis. 2024-4-17

[8]
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial-Mesenchymal Transition.

Cancers (Basel). 2025-1-12

[9]
Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.

Cancer Med. 2024-11

[10]
Onco-Ontogeny of Squamous Cell Cancer of the First Pharyngeal Arch Derivatives.

Int J Mol Sci. 2024-9-16

本文引用的文献

[1]
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Cell. 2016-3-24

[2]
Bcl-2 is a critical mediator of intestinal transformation.

Nat Commun. 2016-3-9

[3]
Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.

Cancer Lett. 2016-5-1

[4]
Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.

J Pathol. 2016-4-9

[5]
BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.

EBioMedicine. 2015-10-30

[6]
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.

Nat Commun. 2016-2-4

[7]
Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.

Int J Oncol. 2016-4

[8]
The Wnt signaling pathway in cancer.

Crit Rev Oncol Hematol. 2016-3

[9]
Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.

Cancer Res. 2015-12-30

[10]
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function.

Nature. 2015-12-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索